Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 23
Filtrar
1.
J Eat Disord ; 12(1): 55, 2024 May 03.
Artículo en Inglés | MEDLINE | ID: mdl-38702806

RESUMEN

BACKGROUND: Hypophosphatemia due to excessive carbohydrate administration is considered the primary pathogenesis of refeeding syndrome. However, its association with liver injury and hypoglycemia, often seen in severe malnutrition before re-nutrition, remains unclear. Autophagy reportedly occurs in the liver of patients with severe malnutrition. This study aimed to clarify the pathophysiology of liver injury and hypoglycemia by focusing on liver volume. METHODS: Forty-eight patients with anorexia nervosa with a body mass index (BMI) of < 13 kg/m2 were included (median BMI: 10.51 kg/m2 on admission). Liver volume was measured in 36 patients who underwent abdominal computed tomography (CT), and the "estimated liver weight/ideal body weight" was used as the liver volume index. Seventeen blood test items were analyzed during the first 60 days. RESULTS: Liver volume significantly decreased when abdominal CTs were conducted shortly before or after hypoglycemia compared to when the scans were performed during periods without hypoglycemia. Five patients with severe hypoglycemia on days 13-18 after admission had a very low nutritional intake; of them, four showed a marked decrease in liver volume. Severe hypoglycemia was accompanied by low serum triglycerides and liver dysfunction. Patients experiencing hypoglycemia of blood glucose levels < 55 mg/dL (< 3.05 mmol/L) (32 patients; median lowest BMI: 9.45 kg/m2) exhibited significantly poorer blood findings for most of the 17 items, except serum phosphorus and potassium, than did those not experiencing hypoglycemia (16 patients; median lowest BMI: 11.2 kg/m2). All patients with a poor prognosis belonged to the hypoglycemia group. Empirically, initiating re-nutrition at 500 kcal/day (20-25 kcal/kg/day), increasing to 700-800 kcal/day after a week, and then gradually escalating can reduce serious complications following severe hypoglycemia. CONCLUSIONS: Liver volume reduction accompanied by hypoglycemia, low serum triglyceride levels, and liver dysfunction occurs when the body's stored energy sources are depleted and external nutritional intake is inadequate, suggesting that the liver was consumed as a last resort to obtain energy essential for daily survival. This pathophysiology, distinct from refeeding syndrome, indicates the terminal stage of malnutrition and is a risk factor for complications and poor prognosis. In treatment, extremely low nutrient levels should be avoided.


This study aimed to clarify the pathophysiology of severe malnutrition in patients with anorexia nervosa by focusing on liver volume. The small size of the liver was almost always accompanied by hypoglycemia within a week. In several cases, extremely low nutritional intake, continued for approximately 2 weeks after admission, resulted in severe hypoglycemia and a marked decrease in liver volume. The 32 patients with hypoglycemia presented worse blood test items related to liver function, nutrition, and blood cell count compared to the 16 patients without such a condition. All cases with poor prognosis were in the hypoglycemia group. These findings suggest that severe hypoglycemia with decreased liver volume indicates the end stage of malnutrition. Liver volume reduction is considered a reflection of the liver's consumption of itself as a last resort for energy procurement for daily survival when the body's stored energy sources are depleted, and external nutritional intake is insufficient. When managing such patients, extremely low nutritional administration should be avoided.

2.
Case Rep Psychiatry ; 2023: 4899364, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-36891160

RESUMEN

Objective: Borna disease virus 1 (BoDV-1) was proven to cause fatal encephalitis in humans in 2018. However, the effects of persistent infections remain unclear. Here, we present the case of a 50-year-old woman with a 30-year history of severe schizophrenia, who was exposed to fleas from stray cats prior to disease onset, suggesting the possibility of zoonosis including BoDV-1 infection. The patient had experienced significant social impairment, thought deterioration, delusions, and hallucinations for more than 20 years. Method: A radioligand assay was used to test the patient for IgG and IgM antibodies against BoDV-1 nucleoprotein (N) and phosphoprotein (P). Based on the protocol for hepatitis C, we treated the patient with 400 mg/day ribavirin, which was later increased to 600 mg/day. Results: The serological examination revealed anti-BoDV-1 N IgG. Although only subtle changes were observed over the 24 weeks of treatment, the family noticed that the patient's Cotard delusions had disappeared 7 months after completing the treatment, accompanied by some improvements in the relationship with the family. Conclusion: Though definite proof was not obtained, this presumed suppression of BoDV-1 by ribavirin leading to improvements in Cotard syndrome-like symptoms suggests that intractable schizophrenia might be one of the BoDV-1 infection phenotypes. Further studies are needed to clarify the effect of persistent BoDV-1 infections in humans.

3.
Vaccines (Basel) ; 10(2)2022 Jan 24.
Artículo en Inglés | MEDLINE | ID: mdl-35214636

RESUMEN

Anti-SARS-CoV-2 antibodies of 444 vaccinated hospital employees in Japan were measured 94-109 days and 199-212 days after receiving the second BNT162b2 vaccine dose to evaluate the intensity and duration of antibody response in our own cohort. Among uninfected participants, anti-S antibody levels were greatly decreased 199-212 days after the second vaccination compared to the levels measured 94-109 days after the second vaccination (median levels: 830 AU/mL and 2425 AU/mL, respectively; p < 0.001). The rate of decrease between the two testing periods was lower in infected participants than in uninfected participants (median: 47.7% and 33.9%, respectively; p < 0.001). Anti-S antibody levels were significantly higher in females (median: females, 2546 AU/mL; males, 2041 AU/mL; p = 0.002 during the first test period). The peak body temperature after vaccination was higher in females than in males (median: females, 37.4 °C; males: 37.1 °C; p = 0.044). Older males tended to have lower antibody levels. In conclusion, the duration of the anti-S antibody response to the BNT162b2 vaccine was short-lived, particularly in males. Anti-S antibody levels of 1000 AU/mL or lower according to SARS-CoV-2 IgG II Quant (Abbott) might indicate insufficient prevention against the delta variant, and the majority of participants appeared to have lost their protection 200 days after vaccination.

4.
Viruses ; 13(2)2021 02 23.
Artículo en Inglés | MEDLINE | ID: mdl-33672213

RESUMEN

This study aimed to clarify whether infection by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is prevalent among the staff of a hospital providing treatment to patients with severe coronavirus disease 2019 (COVID-19) using radioligand assay (RLA). One thousand samples from the staff of a general hospital providing treatment to patients with severe COVID-19 were assayed for SARS-CoV-2 nucleocapsid protein (N) IgG using RLA. Nine patients with COVID-19 who had been treated in inpatient settings and had already recovered were used as control subjects, and 186 blood donor samples obtained more than 10 years ago were used as negative controls. Four of the 1000 samples showed apparently positive results, and approximately 10 or more samples showed slightly high counts. Interestingly, a few among the blood donor samples also showed slightly high values. To validate the results, antibody examinations using ELISA and neutralizing antibody tests were performed on 21 samples, and chemiluminescence immunoassay (CLIA) was performed on 201 samples, both resulting in a very high correlation. One blood donor sample showed slightly positive results in both RLA and CLIA, suggesting a cross-reaction. This study showed that five months after the pandemic began in Japan, the staff of a general hospital with a tertiary emergency medical facility had an extremely low seroprevalence of the antibodies against SARS-CoV-2. Further investigation will be needed to determine whether the slightly high results were due to cross-reactions or a low titer of anti-SARS-CoV-2 antibodies. The quantitative RLA was considered sensitive enough to detect low titers of antibodies.


Asunto(s)
Anticuerpos Antivirales/sangre , COVID-19 , Proteínas de la Nucleocápside de Coronavirus/inmunología , Inmunoglobulina G/sangre , Personal de Hospital , Adulto , Anciano , Anciano de 80 o más Años , Anticuerpos Neutralizantes/sangre , COVID-19/epidemiología , COVID-19/inmunología , Femenino , Humanos , Japón , Masculino , Persona de Mediana Edad , Pandemias , Fosfoproteínas/inmunología , Prevalencia , Estudios Seroepidemiológicos , Adulto Joven
6.
Jpn J Infect Dis ; 71(5): 338-342, 2018 Sep 21.
Artículo en Inglés | MEDLINE | ID: mdl-29848841

RESUMEN

While we previously detected anti-bornavirus antibodies via radioligand assay in psychiatric patients, we did not examine the viral pathogenicity in these individuals. Herein, we present 2 psychiatric patients who were seropositive for bornavirus and whose treatment-resistant symptoms improved after oral administration of ribavirin, a broad-spectrum antiviral agent. Cerebrospinal fluid analysis indicated that ribavirin affected the central nervous system of these patients. Ribavirin ameliorated intermittent involuntary head shaking, which is reminiscent of a symptom observed in bornavirus-infected animals. Using radioligand assays to examine the serial sera of these patients, we found a relationship between the titers of anti-bornavirus antibodies and the change in the patients' symptoms. Our findings suggest there is a relationship between bornavirus infection and human symptoms and that ribavirin may be useful in suppressing chronic bornavirus infection in some neuropsychiatric patients. However, the possibility remains that some other known or unknown virus other than bornavirus that is sensitive to ribavirin may have caused the symptoms. Additional evidence that directly indicates the causative relationship between bornavirus infection and human symptoms is needed before establishing the pathogenesis and treatment for human bornavirus infection.


Asunto(s)
Antivirales/administración & dosificación , Bornaviridae/aislamiento & purificación , Infecciones del Sistema Nervioso Central/diagnóstico , Infecciones del Sistema Nervioso Central/tratamiento farmacológico , Infecciones por Mononegavirales/diagnóstico , Infecciones por Mononegavirales/tratamiento farmacológico , Ribavirina/administración & dosificación , Administración Oral , Adulto , Anticuerpos Antivirales/sangre , Infecciones del Sistema Nervioso Central/patología , Femenino , Humanos , Masculino , Infecciones por Mononegavirales/patología , Resultado del Tratamiento
7.
Microbiol Immunol ; 2018 May 22.
Artículo en Inglés | MEDLINE | ID: mdl-29786872

RESUMEN

Bornavirus infection is observed in both animals, including humans. However, bornavirus epidemiology in humans, especially in children, remains unclear. Here, we evaluated antibodies against bornaviruses in Japanese children with autism spectrum disorder (ASD) using immunofluorescence analysis, western blotting, and radio ligand assay. The prevalence of antibodies against bornavirus-specific speckles, N, and P proteins were 22%, 48%, and 33%, respectively, in the ASD children. According to our criteria, the prevalence of antibodies against bornaviruses was 7.4% in the ASD children. This is the first report of the serological prevalence of bornavirus in Japanese children. Our results provide valuable baseline-data regarding bornavirus epidemiology in children for future studies.

8.
Intern Med ; 57(7): 1011-1013, 2018 Apr 01.
Artículo en Inglés | MEDLINE | ID: mdl-29225271

RESUMEN

We report a rare case of anti-α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor (AMPAR) encephalitis presenting clinical relapse in association with recurrence of thymoma. Anti-AMPAR encephalitis is an autoimmune-mediated neurological disease, frequently accompanied by the presence of neoplasms, thus comprising the spectrum of paraneoplastic syndrome. A patient had been in remission for 34 months showed clinical relapse 3 months after the detection of recurrent thymoma. Clinical relapse of anti-AMPAR encephalitis after the recurrence of an initially detected neoplasm has not been previously reported. Our case therefore highlights the pathogenic relevance of specific tumor antigens as a trigger of anti-AMPAR antibody production and induction of the disease.


Asunto(s)
Corticoesteroides/uso terapéutico , Encefalitis Antirreceptor N-Metil-D-Aspartato/tratamiento farmacológico , Encefalitis Antirreceptor N-Metil-D-Aspartato/etiología , Enfermedad Crónica/terapia , Recurrencia Local de Neoplasia/etiología , Timoma/complicaciones , Neoplasias del Timo/complicaciones , Adulto , Encefalitis Antirreceptor N-Metil-D-Aspartato/diagnóstico por imagen , Femenino , Humanos , Resultado del Tratamiento
9.
Jpn J Infect Dis ; 70(5): 599, 2017.
Artículo en Inglés | MEDLINE | ID: mdl-28943599

RESUMEN

Volume 70, no 2, p.225-227, 2017. Page 226, Figure 1B and C should appear as shown below.

10.
Am J Emerg Med ; 35(8): 1211.e1-1211.e2, 2017 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-28460810

RESUMEN

We present the case of a 47-year-old man with schizophrenia who developed acute and persistent circulatory failure after receiving injections of paliperidone palmitate. We measured blood concentrations of paliperidone and performed resection of hip tissues, where paliperidone palmitate was suspected to be present, in order to reduce the side effects. Unfortunately, the resection could not save the patient from prolonged and severe side effects and he died of multiple organ failure. We suggest that resection of the tissues suspected of containing paliperidone palmitate can help reduce its severe side effects. However, identifying the site of injection is essential.


Asunto(s)
Antipsicóticos/administración & dosificación , Inyecciones Intramusculares/efectos adversos , Insuficiencia Multiorgánica/inducido químicamente , Palmitato de Paliperidona/administración & dosificación , Esquizofrenia/tratamiento farmacológico , Choque/inducido químicamente , Antipsicóticos/efectos adversos , Nalgas , Relación Dosis-Respuesta a Droga , Esquema de Medicación , Resultado Fatal , Humanos , Japón , Masculino , Persona de Mediana Edad , Palmitato de Paliperidona/efectos adversos , Cooperación del Paciente/psicología
11.
BMC Psychiatry ; 17(1): 99, 2017 03 20.
Artículo en Inglés | MEDLINE | ID: mdl-28320371

RESUMEN

BACKGROUND: Patients with psychiatric disorders have a high rate of suicide. The present study investigated factors influencing hospital stays for Japanese patients with psychiatric disorders attempting suicide by jumping. METHODS: We diagnosed all suicide attempts (n = 113) by jumping based on the International Classification of Diseases 10th Revision (ICD-10) and investigated the mean hospital stays of patients with each diagnosis based on the ICD-10 code. We then analyzed differences in the demographic and clinical characteristics between the diagnostic groups to identify factors influencing the duration of hospital stay. RESULTS: Patients diagnosed with schizophrenia (F2 code) were the most frequent (32.7%) of all diagnoses; therefore, we divided the diagnostic groups into schizophrenia group (n = 37) and other psychiatric diagnoses group (n = 76). The patients with schizophrenia showed a significantly longer hospital stay (125.7 ± 63.9 days) compared with the patients with other psychiatric diagnoses (83.6 ± 63.2) (ß ± SE = 42.1 ± 12.7, p = 0.0013), whereas there was no difference in the jump height between the two groups (the average was the 3rd to 4th floor; p > 0.05). The number of injured parts, particularly lower-limb fractures, was significantly higher (p = 0.017) in patients with schizophrenia than in patients with other psychiatric diagnoses. The duration of psychiatric treatment in patients with schizophrenia were significantly longer (z = 3.4, p = 0.001) than in patients with other psychiatric diagnoses. CONCLUSION: Our findings indicate that the number of injuries and the body parts injured in patients with schizophrenia are associated with a longer duration of hospital stay following a suicide attempt by jumping. The current use of antipsychotics and a longer duration of taking antipsychotics might contribute to the risk of bone fracture via hyperprolactinemia. Further cognitive impairment in patients with schizophrenia might prevent rehabilitation for the management of lower-limb fractures. From these results, we suggest that clinicians should monitor the level of prolactin and cognitive function in patients with schizophrenia in future studies on managing of lower-limb fractures.


Asunto(s)
Tiempo de Internación/estadística & datos numéricos , Trastornos Mentales/epidemiología , Trastornos Mentales/psicología , Esquizofrenia/epidemiología , Psicología del Esquizofrénico , Intento de Suicidio/psicología , Intento de Suicidio/estadística & datos numéricos , Adulto , Antipsicóticos/efectos adversos , Antipsicóticos/uso terapéutico , Femenino , Fracturas Óseas/inducido químicamente , Humanos , Hiperprolactinemia/inducido químicamente , Japón , Traumatismos de la Pierna/inducido químicamente , Masculino , Trastornos Mentales/tratamiento farmacológico , Persona de Mediana Edad , Estudios Retrospectivos , Factores de Riesgo , Esquizofrenia/tratamiento farmacológico , Heridas y Lesiones/epidemiología , Heridas y Lesiones/psicología , Adulto Joven
13.
Arch Gynecol Obstet ; 290(5): 883-9, 2014 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-24927782

RESUMEN

PURPOSE: To assess and compare maternal and neonatal outcomes of pregnancy with or without mental disorders. METHODS: We performed a retrospective cohort study of births at our institution from January 2009 to December 2011, which included all live singleton births during these 3 years. Women emergently transferred to our institution in the middle of their pregnancies were excluded. Associations between mental disorders and perinatal outcomes were estimated using statistical analysis, and multivariable analysis was performed using propensity score-based weighting. RESULTS: A total of 1,166 women were included, 152 (13.0 %) of whom had mental disorders. Comparison of maternal characteristics showed that women with mental disorders were significantly more likely to be multiparous, smokers, recipients of public assistance, unmarried, and to have inadequate perinatal care. Comparison of perinatal outcomes showed that preterm births (PTB) before 37 weeks were significantly increased in women with mental disorders (10.5 vs. 6.0 %, P = 0.037). There were no significant differences in low birth weight (LBW), pregnancy-induced hypertension, and gestational diabetes mellitus. Multivariable analysis using propensity score weighting showed that after adjusting for other factors, women with mental disorders were more likely than women without mental disorders to have PTB before 34 weeks [adjusted odds ratio (OR) 4.79, 95 % confidence interval (CI) 1.49-15.4; P = 0.009], PTB before 37 weeks (adjusted OR 2.46, 95 % CI 1.62-3.69; P < 0.001), or LBW (adjusted OR 1.83; 95 % CI 1.32-2.55; P < 0.001). CONCLUSION: Maternal mental disorders were associated with adverse birth outcomes and socioeconomic disadvantage.


Asunto(s)
Recién Nacido de Bajo Peso , Trastornos Mentales/epidemiología , Complicaciones del Embarazo/epidemiología , Resultado del Embarazo/epidemiología , Adulto , Diabetes Gestacional/epidemiología , Diabetes Gestacional/etiología , Femenino , Humanos , Hipertensión Inducida en el Embarazo/epidemiología , Hipertensión Inducida en el Embarazo/etiología , Recién Nacido , Japón/epidemiología , Edad Materna , Trastornos Mentales/complicaciones , Trastornos Mentales/psicología , Oportunidad Relativa , Paridad , Embarazo , Complicaciones del Embarazo/diagnóstico , Complicaciones del Embarazo/psicología , Nacimiento Prematuro/epidemiología , Nacimiento Prematuro/etiología , Puntaje de Propensión , Estudios Retrospectivos , Factores de Riesgo , Adulto Joven
14.
J Affect Disord ; 150(2): 695-8, 2013 Sep 05.
Artículo en Inglés | MEDLINE | ID: mdl-23701752

RESUMEN

BACKGROUND: A history of psychiatric disorders is a high risk for suicide. The present study compared the clinical features of psychiatric patients in Japan who attempted suicide by jumping from a height and those who attempted suicide by self-stabbing. METHODS: We compared two groups of suicide attempters who were hospitalized for both physical and psychiatric treatment (n=202). We compared the psychiatric diagnoses and clinical features between those who attempted suicide by jumping from a height (N=147) and those who did so by self-stabbing (N=55). RESULTS: The self-stabbing group (mean age 52.3 years) was significantly older compared to the jumping group (mean age 37.9 years). A significantly higher proportion of females were found in the jumping group. Jumping from a height was significantly associated with schizophrenia spectrum disorders, whereas self-stabbing was significantly associated with mood disorders. LIMITATIONS: The results were drawn from data from a single hospital in a large urban city, and the study population did not include subjects who completed their suicide attempts. CONCLUSIONS: Our findings show that differences in suicide methods (here, between jumping from a height and self-stabbing) may be related to suicide attempters' psychiatric diagnosis, gender and age. It is thus important to obtain a more detailed background information about a patient's suicide attempt and to create suicide prevention plans in accord with individuals' psychiatric diagnosis, age and gender, especially among those who have attempted suicide by jumping from a height or self-stabbing.


Asunto(s)
Conducta Autodestructiva , Intento de Suicidio/estadística & datos numéricos , Adulto , Factores de Edad , Femenino , Humanos , Japón , Masculino , Trastornos Mentales/diagnóstico , Persona de Mediana Edad , Factores Sexuales , Intento de Suicidio/prevención & control , Intento de Suicidio/psicología
16.
Gen Hosp Psychiatry ; 35(3): 327.e1-327.e3, 2013.
Artículo en Inglés | MEDLINE | ID: mdl-22840564

RESUMEN

OBJECTIVE: Memantine has been reported to have positive effects on visual hallucinations and cognition in patients with dementia with Lewy bodies (DLB). We hypothesized that memantine would have similar effects on a patient having Charles Bonnet syndrome, preclinical DLB. METHOD: We evaluated the effect of memantine on visual hallucination, cognitive abilities and so on from baseline to 4 months after the start of medication. RESULTS: Treatment of the patient with memantine resulted in the disappearance of visual hallucinations but could not stop the progression to dementia. CONCLUSIONS: Our results suggested that, for a patient having preclinical DLB, memantine had some degree of positive effects, but the mechanism remains to be revealed.


Asunto(s)
Antiparkinsonianos/uso terapéutico , Enfermedad por Cuerpos de Lewy/tratamiento farmacológico , Memantina/uso terapéutico , Síntomas Prodrómicos , Anciano , Disfunción Cognitiva/tratamiento farmacológico , Disfunción Cognitiva/etiología , Femenino , Alucinaciones/tratamiento farmacológico , Alucinaciones/etiología , Humanos , Enfermedad por Cuerpos de Lewy/complicaciones , Resultado del Tratamiento
17.
Gen Hosp Psychiatry ; 33(4): 407-9, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21762839

RESUMEN

OBJECTIVE: The aim of the present study was to determine the efficacy of ramelteon for treating delirium. METHODS: Three patients were prescribed ramelteon for delirium. The severity of the delirium was assessed using the Japanese version of the Memorial Delirium Assessment Scale. RESULTS: Memorial Delirium Assessment Scale scores improved after treatment with ramelteon in all cases. CONCLUSION: These cases suggest that ramelteon may be beneficial in the treatment of delirium. Randomized controlled studies are needed to confirm the therapeutic benefits.


Asunto(s)
Delirio/tratamiento farmacológico , Indenos/uso terapéutico , Satisfacción del Paciente , Psicotrópicos/uso terapéutico , Anciano , Anciano de 80 o más Años , Femenino , Humanos , Indenos/administración & dosificación , Japón , Persona de Mediana Edad , Evaluación de Resultado en la Atención de Salud , Índice de Severidad de la Enfermedad
18.
Gen Hosp Psychiatry ; 32(4): 447.e3-5, 2010.
Artículo en Inglés | MEDLINE | ID: mdl-20633757

RESUMEN

OBJECTIVE: To highlight the association between posterior reversible encephalopathy syndrome (PRES) and chronic alcoholism. METHODS: We present a case report, a review of the literature and a discussion. RESULTS: We report on the case of a 51-year-old man with chronic alcoholism, who suddenly developed visual disturbance and confusion. Magnetic resonance imaging (MRI) on admission demonstrated abnormal findings. However, clinical symptoms and imaging promptly improved, indicating the diagnosis of PRES. CONCLUSION: PRES should be considered when making a diagnosis for disturbed consciousness in alcoholic patients.


Asunto(s)
Alcoholismo/complicaciones , Síndrome de Leucoencefalopatía Posterior/etiología , Enfermedad Aguda , Alcoholismo/psicología , Ceguera/complicaciones , Alucinaciones/complicaciones , Humanos , Imagen por Resonancia Magnética , Masculino , Persona de Mediana Edad , Síndrome de Leucoencefalopatía Posterior/diagnóstico , Trastornos Psicóticos/complicaciones
19.
Antiviral Res ; 80(3): 380-4, 2008 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-18778737

RESUMEN

By using neonatal gerbils, we assessed the effect of ribavirin on the proliferation of Borna disease virus (BDV) in the brain. The intracranial inoculation of ribavirin reduced viral propagation in the acutely infected brain, resulting in protection from fatal neurological disorders. We found that the treatment with ribavirin markedly reduces the numbers of OX-42-positive microglial cells, but does not activate expression of Th1 cytokines, in BDV-infected gerbil brains. Our results suggested that ribavirin directly inhibits BDV replication and might be a potential tool for the treatment of BDV infection.


Asunto(s)
Animales Recién Nacidos/virología , Antivirales/farmacología , Enfermedad de Borna/tratamiento farmacológico , Virus de la Enfermedad de Borna/efectos de los fármacos , Enfermedades del Sistema Nervioso/veterinaria , Ribavirina/farmacología , Enfermedades de los Roedores/tratamiento farmacológico , Replicación Viral/efectos de los fármacos , Animales , Enfermedad de Borna/virología , Virus de la Enfermedad de Borna/fisiología , Encéfalo/virología , Femenino , Gerbillinae , Masculino , Enfermedades del Sistema Nervioso/tratamiento farmacológico , Enfermedades del Sistema Nervioso/virología , Enfermedades de los Roedores/virología
20.
J Clin Virol ; 43(3): 317-22, 2008 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-18786855

RESUMEN

BACKGROUND: Borna disease virus (BDV) infection of humans has not been widely accepted due to the low titer of the antibody and lack of reliable diagnostic tools. OBJECTIVES: To examine exposure to BDV or a related virus in Japanese psychiatric and general population by detecting the specific IgG, IgM, and IgA. STUDY DESIGN: Sera from 304 psychiatric and 378 control subjects were examined for IgG, IgM, and IgA against BDV nucleoprotein (N) and phosphoprotein (P) using highly specific and sensitive radioligand assay. The avidity was also examined. RESULTS: The specific IgG, IgM, and IgA against both BDV-N and -P were detected and the seropositivity was not significantly different between patients and controls. The avidity of the specific IgG was low to moderate, and the specific IgM did not disappear for several years. CONCLUSIONS: Our results suggested common exposure to BDV or a related virus in the general Japanese population. Low avidity IgG and persistent IgM suggested delayed immune response against BDV or a related virus. The specific IgA indicated mucosal involvement.


Asunto(s)
Anticuerpos Antivirales/sangre , Enfermedad de Borna/epidemiología , Enfermedad de Borna/inmunología , Virus de la Enfermedad de Borna/inmunología , Inmunoglobulina A/sangre , Inmunoglobulina G/sangre , Inmunoglobulina M/sangre , Adulto , Anciano , Afinidad de Anticuerpos , Antígenos Virales/inmunología , Femenino , Humanos , Japón/epidemiología , Masculino , Persona de Mediana Edad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...